Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 4/20 | 0.56 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.56 |
| ▸ | GLP1R | P43220 | 10/20 | 0.55 |
| ▸ | KDM1A | O60341 | 1/20 | 0.53 |
| ▸ | NPY1R | P25929 | 2/20 | 0.52 |
| ▸ | NPY2R | P49146 | 2/20 | 0.52 |
| ▸ | NPY4R | P50391 | 2/20 | 0.52 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.52 |
| ▸ | SCTR | P47872 | 1/20 | 0.52 |
| ▸ | BECN1 | Q14457 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30168734 | 1.00 | F2 (0.56) | F2KEAP1GLP1RKDM1ANPY1R | |
| SCHEMBL30168770 | 0.99 | F2 (0.58) | F2KEAP1GLP1RKDM1ANPY1R | |
| SCHEMBL29836365 | 0.97 | F2 (0.55) | F2KEAP1GLP1RKDM1ASCTR | |
| SCHEMBL29836528 | 0.97 | F2 (0.55) | F2KEAP1GLP1RKDM1ASCTR | |
| SCHEMBL30168691 | 0.97 | KEAP1 (0.56) | F2KEAP1GLP1RKDM1ANPY1R | |
| SCHEMBL29836324 | 0.96 | F2 (0.57) | F2KEAP1GLP1RKDM1ASCTR | |
| SCHEMBL30168702 | 0.96 | MAPK8 (0.56) | F2KEAP1GLP1RKDM1ABECN1 | |
| SCHEMBL30168757 | 0.96 | KEAP1 (0.55) | F2KEAP1GLP1RNPY1RNPY2R | |
| SCHEMBL30168694 | 0.95 | KEAP1 (0.59) | F2KEAP1GLP1RKDM1ANPY1R | |
| SCHEMBL30168767 | 0.95 | KEAP1 (0.59) | F2KEAP1GLP1RNPY1RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12428638-B2 | Three-component CRISPR/Cas complex system and uses thereof | THE JACKSON LABORATORY (US) | 2025-09-30 | — | — | US | disclosed |
| US-20230071712-A1 | THREE-COMPONENT CRISPR/CAS COMPLEX SYSTEM AND USES THEREOF | THE JACKSON LABORATORY (US) | 2023-03-09 | — | — | US | disclosed |